Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

US drug reimportation 'Trump proposal' risky and inefficient, AmerisourceBergen

AmerisourceBergan has warned of the dangers of reimportation a day after the Senate rejected Bernie Sanders’ “Trump proposal” to overturn the ban.

Recipharm and Laccure agreement to span 'several years'

Recipharm has entered into a collaboration with Laccure AB for the commercial manufacture and delivery of Laccure® Pessary.

Sobi and Horizon make 5 year commitment to distribute their drugs in Europe

Swedish Orphan Biovitrum AB (Sobi) and Horizon Pharma plc have teamed up for a 5-year deal to distribute urea cycle disorder drugs Ravicti and Ammonaps in Europe and the Middle East.

News in brief

Fareva opens aerosol plant as part of $40m drug and OTC business investment

Fareva Group has set up an aerosol manufacturing facility at its site in Richmond, Virginia as part of a $40m (€37m) investment in its drug, OTC medicine and beauty care business.

MilliporeSigma to speed up production of Acticor’s antibody against stroke

Acticor Biotech has made a deal with Merck KGaA’s CMO MilliporeSigma to use its Provantage End-to-End services to make its anti-thrombotic antibody fragment ACT-017 for stroke.

Almac, inVentiv announce strategic partnership

Almac Clinical Technologies, part of the Almac Group, has announced a strategic partnership with the contract research organization (CRO) inVentiv Health.

Promotional Features

Key Industry Events


Access all events listing

Our events, Shows & Conferences...